Microchip CFO’s trust sells 5,530 shares

Microchip Technology Senior VP and CFO James Eric Bjornholt reported indirect open-market sales of a total of 5,530 shares of common stock held by a trust associated with him.

Accepted by SEC EDGAR 02/26/2026 - 04:27 PM EST Learn about SEC filing dates

Rhea-AI Filing Summary

Microchip Technology Senior VP and CFO James Eric Bjornholt reported indirect open-market sales of a total of 5,530 shares of common stock held by a trust associated with him. The sales on February 24, 2026 occurred at prices of $77.09 and $78.93 per share under a pre-arranged Rule 10b5-1 trading plan adopted on May 23, 2025. After these transactions, 28,142 shares were reported as indirectly held.

Insider Trade Summary

Net Seller: 5,530 shares

Net Sell 2 txns

Insider Bjornholt James Eric

Role SENIOR VP AND CFO

Sold 5,530 shs ($430K)

Type	Security	Shares	Price	Value
Sale	Common Stock	3,530	$77.09	$272K
Sale	Common Stock	2,000	$78.93	$158K

Holdings After Transaction: Common Stock — 28,142 shares (Indirect, Shares held Indirectly, by Trust.)

Footnotes (1)

1. F1. The sale(s) reported in this Form 4 was/were effected pursuant to a Rule 10b5-1 trading plan adopted by the Reporting Person on May 23, 2025.

FAQ

AI-generated questions and answers. How Rhea-AI works. Not financial advice.

What insider transaction did Microchip Technology (MCHP) report for James Eric Bjornholt?

Microchip Technology reported that a trust associated with Senior VP and CFO James Eric Bjornholt sold 5,530 shares of common stock. These were indirect holdings, and the sales were executed in open-market transactions under a Rule 10b5-1 trading plan.

How many Microchip Technology (MCHP) shares were sold in this Form 4 filing and at what prices?

The filing shows total sales of 5,530 Microchip Technology common shares. One block of 3,530 shares sold at $77.09 per share, and another 2,000 shares sold at $78.93 per share, all in open-market transactions reported as indirect trust holdings.

Were the Microchip Technology (MCHP) insider sales by the CFO pre-planned under Rule 10b5-1?

Yes. The footnote states the reported sales were executed under a Rule 10b5-1 trading plan adopted by the reporting person on May 23, 2025. Such plans allow preset trading instructions, helping separate routine diversification from discretionary trading decisions.

Does the Microchip Technology (MCHP) Form 4 show direct or indirect ownership for these shares?

The Form 4 identifies the transactions as indirect ownership, noting the shares are held by a trust. The nature of ownership field specifies “Shares held Indirectly, by Trust,” meaning the trust, rather than the individual personally, is the direct holder of the stock.

How many Microchip Technology (MCHP) shares remain held after the reported insider sales?

After the reported trust sales, the Form 4 shows 28,142 Microchip Technology common shares remaining as indirectly held. This post-transaction figure reflects the holdings associated with the reporting person through the trust following both open-market sale transactions.

Who is the insider involved in the Microchip Technology (MCHP) Form 4 transaction?

The insider is James Eric Bjornholt, Senior Vice President and Chief Financial Officer of Microchip Technology. He is the reporting person on the Form 4, with the disclosed transactions involving shares held indirectly through a trust associated with him.

AI-generated analysis. How Rhea-AI works. Not financial advice.

Form 4 Insider Transactions: What Each Field Means →

See more from StockTitan in Google Search and AI answers. Adds StockTitan as a preferred source · opens Google

Add on Google Not now

SEC Form 4

FORM 4

UNITED STATES SECURITIES AND EXCHANGE COMMISSION
Washington, D.C. 20549

STATEMENT OF CHANGES IN BENEFICIAL OWNERSHIP

Filed pursuant to Section 16(a) of the Securities Exchange Act of 1934
or Section 30(h) of the Investment Company Act of 1940

OMB APPROVAL

OMB Number:			3235-0287
Estimated average burden
hours per response:			0.5

Check this box if no longer subject to Section 16. Form 4 or Form 5 obligations may continue. See Instruction 1(b).

X

Check this box to indicate that a transaction was made pursuant to a contract, instruction or written plan for the purchase or sale of equity securities of the issuer that is intended to satisfy the affirmative defense conditions of Rule 10b5-1(c). See Instruction 10.

1. Name and Address of Reporting Person^*

Bjornholt James Eric

(Last) (First) (Middle)

C/O MICROCHIP TECHNOLOGY INCORPORATED

2355 WEST CHANDLER BOULEVARD

(Street)

CHANDLER AZ 85224-6199

(City) (State) (Zip)

2. Issuer Name and Ticker or Trading Symbol
MICROCHIP TECHNOLOGY INC [ MCHP ]

5. Relationship of Reporting Person(s) to Issuer
(Check all applicable)

	Director		10% Owner
X	Officer (give title below)		Other (specify below)
	SENIOR VP AND CFO

3. Date of Earliest Transaction (Month/Day/Year)
02/24/2026

4. If Amendment, Date of Original Filed (Month/Day/Year)

6. Individual or Joint/Group Filing (Check Applicable Line)

X	Form filed by One Reporting Person
	Form filed by More than One Reporting Person

Table I - Non-Derivative Securities Acquired, Disposed of, or Beneficially Owned
1. Title of Security (Instr. 3)	2. Transaction Date (Month/Day/Year)	2A. Deemed Execution Date, if any (Month/Day/Year)	3. Transaction Code (Instr. 8)		4. Securities Acquired (A) or Disposed Of (D) (Instr. 3, 4 and 5)			5. Amount of Securities Beneficially Owned Following Reported Transaction(s) (Instr. 3 and 4)	6. Ownership Form: Direct (D) or Indirect (I) (Instr. 4)	7. Nature of Indirect Beneficial Ownership (Instr. 4)
			Code	V	Amount	(A) or (D)	Price
Common Stock	02/24/2026		S(1)		3,530	D	$77.09	30,142	I	Shares held Indirectly, by Trust.
Common Stock	02/24/2026		S		2,000	D	$78.93	28,142	I	Shares held Indirectly, by Trust.

Table II - Derivative Securities Acquired, Disposed of, or Beneficially Owned (e.g., puts, calls, warrants, options, convertible securities)
1. Title of Derivative Security (Instr. 3)	2. Conversion or Exercise Price of Derivative Security	3. Transaction Date (Month/Day/Year)	3A. Deemed Execution Date, if any (Month/Day/Year)	4. Transaction Code (Instr. 8)		5. Number of Derivative Securities Acquired (A) or Disposed of (D) (Instr. 3, 4 and 5)		6. Date Exercisable and Expiration Date (Month/Day/Year)		7. Title and Amount of Securities Underlying Derivative Security (Instr. 3 and 4)		8. Price of Derivative Security (Instr. 5)	9. Number of derivative Securities Beneficially Owned Following Reported Transaction(s) (Instr. 4)	10. Ownership Form: Direct (D) or Indirect (I) (Instr. 4)	11. Nature of Indirect Beneficial Ownership (Instr. 4)
				Code	V	(A)	(D)	Date Exercisable	Expiration Date	Title	Amount or Number of Shares

Explanation of Responses:

1. The sale(s) reported in this Form 4 was/were effected pursuant to a Rule 10b5-1 trading plan adopted by the Reporting Person on May 23, 2025.

Remarks:

	Deborah L. Wussler, as Attorney-in-Fact	02/26/2026
	** Signature of Reporting Person	Date
Reminder: Report on a separate line for each class of securities beneficially owned directly or indirectly.
* If the form is filed by more than one reporting person, see Instruction 4 (b)(v).
** Intentional misstatements or omissions of facts constitute Federal Criminal Violations See 18 U.S.C. 1001 and 15 U.S.C. 78ff(a).
Note: File three copies of this Form, one of which must be manually signed. If space is insufficient, see Instruction 6 for procedure.
Persons who respond to the collection of information contained in this form are not required to respond unless the form displays a currently valid OMB Number.